Key Areas of Research: Endocrine: Growth hormone, IGF-1, signaling Metabolic: Lipids, lean tissue, glucose balance Cellular: Proliferation, repair, recovery Systemic: Cardiovascular, viability, healing Together, these findings suggest broad experimental potential for CJC-1295 and Ipamorelin across multiple biological pathways
Combined with proper diet, regular exercise, adequate sleep, and stress management, GLP-1 Plus may provide a modest metabolic edge
This peptide could improve symptoms and prolong remission, especially alongside other therapies
SS-31 addresses this fundamental bottleneck
This slow titration is standard for GLP-1 medications and helps minimize side effects, particularly the GI symptoms that are most common early in treatment